Biopolym. Cell. 1999; 15(1):83-87.
http://dx.doi.org/10.7124/bc.00050A
Discussions
A possible general mechanism of the signal transfer switching on the α/β-interferons expression. 2. The role of the cAMP in the process of the interferon induction
1Karpov A. V.
  1. D. K. Zabolotny Institute of Microbiology and Virology, NAS of Ukraine
    154, Academika Zabolotnogo Str., Kyiv, Ukraine, 03680

Abstract

The author carries out an analysis of available data concerning the participation of cyclic adenosine 3',5'-monophosphate (cAMP) in the signal transduction pathway on the α/β-inierferons (IFN) expression during the induction process. The cAMP is known to participate in the activation of protein kinasev during the interferon induction as well as of nuclear factors activating specifically the regulating domains, of IFN genes. The cAMP is thought to be a secondary key messenger mediating the signal, for α/β-lFN induction, the first stage of this induction being the local cell membrane deformation caused by diffirent inducers.
Full text: (PDF, in English)

References

[1] Ho M. Induction and inducers of interferon. Interferon 1. General and applied aspects. Ed. A. Billiau. Amsterdam; New York; Oxford: Elsevier, 1984:79—124.
[2] Marcus P. I. Interferon induction by viruses: double-stranded ribonucleic acid as the common proximal inducer molecule Interferon 3. Mechanisms of production and action. Ed. R. M. Friedman. Amsterdam; New York; Oxford: Elsevier, 1984:113—175.
[3] Stringfellow DA. Induction of interferon with low molecular weight compounds: fluorenone esters, ethers (tilorone), and pyrimidinones. Methods Enzymol. 1981;78(Pt A):262-84.
[4] Torrence P. T., De Clercq E. Interferon induction by nucleic acids: structure-activity relationships. Interferon and their applications. Eds P. E. Came, W. A. Carter. Berlin: Springer, 1984:371—383.
[5] Maniatis T., Whittemore L. A., Du W. et al. Positive and negative control of human interferon-b gene expression Transcriptional regulation. Eds S. L. McKnight, K. R Yamamoto. New York: Cold Spring Harbor Lab. press, 1992:1193—1220.
[6] Taniguchi T. Regulation of cytokine gene expression. Annu Rev Immunol. 1988;6:439-64.
[7] Goodbourn S, Maniatis T. Overlapping positive and negative regulatory domains of the human beta-interferon gene. Proc Natl Acad Sci USA. 1988;85(5):1447-51.
[8] Karpov AV. A possible general mechanism of the signal transfer switching on the a/b-interferons expression. 1. The local cell membrane deformation as the first induction stage. Biopolym. Cell. 1998; 14(6):561-566
[9] Buzhurina I. M., Panov M. A. Mechanisms of cellular response to external stimuli. Obshch. probl. fiz.-khim. biologii. M.: VINITI, 1986: 1—258
[10] Watson PA. Direct stimulation of adenylate cyclase by mechanical forces in S49 mouse lymphoma cells during hyposmotic swelling. J Biol Chem. 1990;265(12):6569-75.
[11] Olesen SP, Clapham DE, Davies PF. Haemodynamic shear stress activates a K+ current in vascular endothelial cells. Nature. 1988;331(6152):168-70.
[12] Wang N, Butler JP, Ingber DE. Mechanotransduction across the cell surface and through the cytoskeleton. Science. 1993;260(5111):1124-7.
[13] Preobrazhenskaia NP, Iurkevich AM. Current concepts concerning the role of cyclic-AMP as a regulator of enzyme activity. Vopr Med Khim. 1973;19(5):451-62.
[14] Sutherland EW.Studies on the mechanism of hormone action. Science. 1972;177(4047):401-8.
[15] Comb M, Birnberg NC, Seasholtz A, Herbert E, Goodman HM. A cyclic AMP- and phorbol ester-inducible DNA element. Nature. 1986;323(6086):353-6.
[16] Gonzalez GA1, Yamamoto KK, Fischer WH, Karr D, Menzel P, Biggs W 3rd, Vale WW, Montminy MR. A cluster of phosphorylation sites on the cyclic AMP-regulated nuclear factor CREB predicted by its sequence. Nature. 1989;337(6209):749-52.
[17] Meldolesi MF, Friedman RM, Kohn LD. An interferon-induced increase in cyclic AMP levels precedes the establishment of the antiviral state. Biochem Biophys Res Commun. 1977;79(1):239-46.
[18] Nishizuka Y. Turnover of inositol phospholipids and signal transduction. Science. 1984;225(4668):1365-70.
[19] Thacore HR, Lin HY, Davis PJ, Schoenl M. Effect of protein kinase C inhibitors on interferon-beta production by viral and non-viral inducers. J Gen Virol. 1990;71 ( Pt 12):2833-9.
[20] Marcus PI, Sekellick MJ. Interferon induction by viruses. XVI. 2-Aminopurine blocks selectively and reversibly an early stage in interferon induction. J Gen Virol. 1988;69 ( Pt 7):1637-45.
[21] Zinn K, Keller A, Whittemore LA, Maniatis T. 2-Aminopurine selectively inhibits the induction of beta-interferon, c-fos, and c-myc gene expression. Science. 1988;240(4849):210-3.
[22] Cambier JC, Newell MK, Justement LB, McGuire JC, Leach KL, Chen ZZ. Ia binding ligands and cAMP stimulate nuclear translocation of PKC in B lymphocytes. Nature. 1987;327(6123):629-32.
[23] Cachelin AB, de Peyer JE, Kokubun S, Reuter H. Ca2+ channel modulation by 8-bromocyclic AMP in cultured heart cells. Nature. 1983;304(5925):462-4.
[24] Katada T, Gilman AG, Watanabe Y, Bauer S, Jakobs KH. Protein kinase C phosphorylates the inhibitory guanine-nucleotide-binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylate cyclase. Eur J Biochem. 1985;151(2):431-7.
[25] Romanchikov YuM. Growth factors, oncogenes, and second messengers. Usp Sovrem Biol. 1991; 111(1):19-33.
[26] Corbin JD, Beebe SJ, Blackmore PF. cAMP-dependent protein kinase activation lowers hepatocyte cAMP. J Biol Chem. 1985;260(15):8731-5.
[27] Hai TW, Liu F, Allegretto EA, Karin M, Green MR. A family of immunologically related transcription factors that includes multiple forms of ATF and AP-1 Genes Dev. 1988;2(10):1216-26.
[28] Hai TW, Liu F, Coukos WJ, Green MR. Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers. Genes Dev. 1989;3(12B):2083-90.
[29] Du W, Maniatis T. An ATF/CREB binding site is required for virus induction of the human interferon beta gene [corrected] Proc Natl Acad Sci U S A. 1992;89(6):2150-4.
[30] Liu F, Green MR. A specific member of the ATF transcription factor family can mediate transcription activation by the adenovirus E1a protein. Cell. 1990;61(7):1217-24.
[31] Hiscott J, Alper D, Cohen L, Leblanc JF, Sportza L, Wong A, Xanthoudakis S. Induction of human interferon gene expression is associated with a nuclear factor that interacts with the NF-kappa B site of the human immunodeficiency virus enhancer. J Virol. 1989;63(6):2557-66.
[32] Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 1986;46(5):705-16.
[33] Sen R, Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell. 1986;47(6):921-8.
[34] Baeuerle PA, Baltimore D. A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB. Genes Dev. 1989;3(11):1689-98.
[35] Ghosh S, Baltimore D. Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B. Nature. 1990;344(6267):678-82.
[36] Shirakawa F, Mizel SB. In vitro activation and nuclear translocation of NF-kappa B catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. Mol Cell Biol. 1989;9(6):2424-30.
[37] Lenardo MJ, Fan CM, Maniatis T, Baltimore D. The involvement of NF-kappa B in beta-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell. 1989;57(2):287-94.
[38] Visvanathan KV, Goodbourn S. Double-stranded RNA activates binding of NF-kappa B to an inducible element in the human beta-interferon promoter. EMBO J. 1989;8(4):1129-38.
[39] Fujita T, Kimura Y, Miyamoto M, Barsoumian EL, Taniguchi T. Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1. Nature. 1989;337(6204):270-2.
[40] Galetyan G. G., Mkhitaryan F. S., Gasparyan N. T. Effect of dsRNA on the content of cyclic nucleotides in various tissues of eukaryotes. Zhurn. eksperim. i klin. meditsiny. 1989. 29, N 5:477—482.
[41] Zemskov VM. Synthetic polynucleotides as nonspecific stimulators of the body's immunological system. Usp Sovrem Biol. 1973;76(4):3-20.
[42] Wathelet MG, Berr PM, Huez GA. Regulation of gene expression by cytokines and virus in human cells lacking the type-I interferon locus. Eur J Biochem. 1992;206(3):901-10.
[43] Winchurch R, Ishizuka M, Webb D, Braun W. Adenyl cyclase activity of spleen cells exposed to immunoenhancing synthetic oligo- and polynucleotides. J Immunol. 1971;106(5):1399-400.
[44] Braun W, Ishizuka M. Cyclic AMP and immune responses. II. Phosphodiesterase inhibitors as potentiators of polynucleotide effects on antibody formation. J Immunol. 1971;107(4):1036-42.
[45] Butcher RW, Sutherland EW. Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine. J Biol Chem. 1962;237:1244-50.
[46] Triner L, Vulliemoz Y, Schwartz I, Nahas GG. Cyclic phosphodiesterase activity and the action of papaverine. Biochem Biophys Res Commun. 1970;40(1):64-9.
[47] Grigorian SS, Poverennyi AM, Ershov FI. Vasodilators as interferon inducers. Vopr Virusol. 1987;32(2):204-8.